What are the Most commonly Occurring Orthopedic Disorders

The growth of this market is primarily driven by the factors such as growing prevelance of dental disorders, increasing demand for the cosmetic dentistry and expanding applications of CBCT.

In addition to this, new product launches and approvals, partnerships, agreements and collaborations among market players and are also providing impetus for the growth of this market.

Moreover, acceptance of the CBCT systems in breast imaging and untapped emerging economies provide significant growth opportunities in the market.

However, high cost of the CBCT systems may hinder the growth of this market during the forecast period.The global CBCT/Cone Beam Imaging Market is expected to reach USD 801.2 Million by 2021 from USD 494.4 Million in 2016, at a CAGR of 10.1% during the forecast period (2016-2021)Ask for PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=226049013Market Segmentation: -In this report, the Global CBCT/cone beam imaging market is segmented on the basis of application, patient position, end user and region.Based on end user, the CBCT/cone beam imaging market is segmented into hospitals, practices and academic and research institutes.

The hospital segment is expected to account for the largest share of the CBCT/cone beam imaging market in 2016.

However, private practices are expected to grow at highest CAGR during the forecast period.Growing awareness of dental healthcare, growth in geriatric population (especially in Japan), increasing prevalence of orthopedic disorders, partnerships/collaborations among key players, growing medical tourism for dental services, improving healthcare infrastructure, and growing disposable incomes in emerging Asian economies (such as China and India) are some of the key factors fuelling the growth of this market.Target Audience:Cone beam computed tomography (CBCT) manufacturers and suppliersDental/ENT/orthopedic associationsDental imaging equipment manufacturersDental/ENT/orthopedic clinics and hospitalsAcademic institutes and universitiesMedical device manufacturersVenture capitalistsResearch and consulting firmsRegional Analysis: -Based on region, the CBCT/cone beam imaging market is segmented into North America, Europe, Asia and Rest of the World (RoW).

The Global Soft Tissue Repair Market is expected to grow significantly over the forecast period.

It is anticipated that the market held a valuation of USD 5200 million in 2017 and is projected to register a CAGR of 6.2% over the forecast period.The rising cases of sports-related injuries and technological advancements are some of the key factors driving the soft tissue repair market.

The xenograft implant is designed for the surgical repair of damaged or ruptured membranes.Various other factors such as increasing awareness about orthopedic disorders and other related conditions, improvement in reimbursement policies, untapped emerging markets, and increasing healthcare expenditure are also expected to propel the growth of the market.However, the high cost of advanced equipment and a shortage of physicians in emerging markets can hamper market growth over the forecast period.SegmentationThe global soft tissue repair market is segmented based on product, application, end user, and region.the global market for soft tissue repair, by product, is segmented into fixation products, tissue patch/match, laparoscopic instrument, and others.

The biological segment includes allograft and xenograft.Based on application, the market is segmented into orthopedic surgery, skin repair, hernia repair, vaginal sling repair, dental reconstruction, cardiovascular surgery, breast reconstruction, and others.Based on end user, the market is segmented into hospitals, clinics, research & academic institutes, and others.In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and African region.The soft tissue repair market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.The European soft tissue repair market has been segmented into Western Europe and Eastern Europe.

Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The soft tissue repair market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.

According to the new market research report “Regenerative Medicine Market by Type [Cell-Based Immunotherapy & Cell Therapy (Allogeneic & Autologous Products), Tissue Engineering, Gene Therapy], Applications (Wounds & Dermal, Musculoskeletal, Oncology), Region — Global Forecast to 2024”, published by MarketsandMarkets™, the Regenerative Medicine Market is expected to reach USD 38.7 billion by 2024 from USD 13.3 billion in 2019, at a CAGR of 23.8%.Growth in this market is largely driven by the introduction of Cures Act for regenerative medicine by FDA, increased funding for regenerative medicine research, development of CAR-T cell therapies and increasing demand for regenerative medicine for the treatment of cancer, orthopedic disorders, and chronic wounds among others.

Cell-based immunotherapy & cell therapy products segment dominated the Regenerative Medicine Market in 2019.On the basis of type, the Regenerative Medicine Market is classified into cell-based immunotherapy & cell therapy products, gene therapy products, and tissue-engineered products.

The cell-based immunotherapy & cell therapy products segment accounted for the largest market share in 2019 owing to increasing demand for cell-based immunotherapies, the establishment of cures act by FDA to streamline the regenerative medicine approval are the major factors driving the growth of this market segment.Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65442579Browse and in-depth TOC on “Regenerative Medicine Market”76 — Tables29 — Figures107 — PagesMusculoskeletal disorders applications segment likely to dominate the market in 2019.On the basis of application, the Regenerative Medicine Market is categorized into musculoskeletal disorders, wound care, oncology, ocular disorders, diabetes, and other applications.

In 2019, the musculoskeletal disorders segment accounted for the largest market share.

The large share of this segment can mainly be attributed to the rising incidence rate of orthopedic diseases with a rising geriatric population.North America anticipated accounting for the largest share of the Regenerative Medicine Market in 2019.The Regenerative Medicine Market in North America is expected to account for the largest share globally and also grow at a faster rate during the forecast period.

Surging research activities in the field of regenerative medicine, the introduction of CAR-T cell therapies and growing awareness of personalized medicine have also resulted in the establishment of stem cell banking and tissue engineering.Read a Press Release on “Regenerative Medicine Market”:https://www.marketsandmarkets.com/PressReleases/regenerative-medicine.aspThe major players in this market are Kite Pharma (US), Novartis (Switzerland), Vericel Corporation (US), Integra LifeSciences (US), Wright Medical (US), MiMedx (US), Osiris Therapeutics (US), Stryker Corporation (US), and Spark Therapeutics (US).

The growth and development of Global Diagnostic X-Ray Imaging Market Report 2020-2026 by Players, Regions, Type, and Application, forecast to 2026 provides industry analysis and forecast from 2020-2026.

Global Diagnostic X-Ray Imaging Market analysis delivers important insights and provides a competitive and useful advantage to the pursuers.

The data chart is also backed up by using statistical tools.Simultaneously, we classify different Diagnostic X-Ray Imaging markets based on their definitions.

Downstream consumers and upstream materials scrutiny are also carried out.

Each segment includes an in-depth explanation of the factors that are useful to drive and restrain it.

Report is a complete, proficient and in-depth research of Diagnostic X-Ray Imaging that conveys critical information for those who are seeking information for the industry.

The global physical therapy equipment market is driven by growing prevalence of orthopedic disorders and rising incidence of sport injuries.

These factors have helped shape the physical therapy equipment market and are expected to boost the growth.

The performance of the physical therapy equipment market has also been studied for the past and current years.

The physical therapy equipment market report provides major information about regional markets of North America, Europe, Asia-Pacific (APAC), and the rest of the world.

The North American physical therapy equipment market has many companies across the United States, Canada, and Mexico.

However, the physical therapy equipment market growth can be affected due to inadequate reimbursement policies for physiotherapy.

Steerable Robotic Catheters Market: IntroductionSteerable robotic catheters are minimally invasive medical devices that have wide application in cardiac surgery, vascular surgery, neurosurgery, orthopedic surgery, gastrointestinal surgery, and uterine surgery.

Steerable robotic catheter allows high levels of control over distal tip, improved access to complex anatomical structures, better catheter stability, and decreased radiation exposure to both physicians as well as patients.Request a PDF Brochure of Steerable Robotic Catheters Market @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=72828Global Steerable Robotic Catheters Market: Key DriversThe global steerable robotic catheters market is primarily driven by high prevalence of cardiovascular disorders, neurovascular disorders, cancer, and orthopedic disorders across the globeAccording to the World Health Organization (WHO), cardiovascular disorder is the main cause of deaths across the globe.

According to WHO, in 2016, more than 17.9 million people died globally due to cardiovascular disorders.Rise in adoption of minimally invasive surgeries, owing to their several advantages, such as, shorter hospital stays, lesser cuts on body, shorter wound healing time, and less traumatic etc., as compared to open surgeries, is likely to fuel the growth of steerable robotic catheters market during the forecast periodTechnological advancements in steerable robotic catheters, including the development of magnetic navigation catheters, is anticipated to drive the steerable robotic catheters during the forecast periodTendon Driven Catheters Segment to Witness Attractive OpportunitiesIn terms of product type, the global steerable robotic catheters market can be divided into tendon driven catheters, magnetic navigation catheters, soft material driven catheters, and hybrid actuation catheters.

Tendon driven catheter is likely to be the leading segment of the market during the forecast period.Tendon driven catheters are used to manipulate distal tip of steerable catheters.

Backbones are made of a variety of materials, such as springs, elastic tubes, braided polymers, and Nitinol alloys.Soft material driven catheters are made of the Nitinol family materials and possess high plasticity, high steerability and torque ability, biocompatibility, and are kink-resistantMagnetic navigation catheters are navigated by placing large magnets on either side of the patient’s body and generates a magnetic field around the patient.

Physicians then manipulate the magnetic field for deflecting the distal tip of catheter inside the patient’s body to the desired location.Cardiac Surgery Segment to Dominate Global MarketIn terms of application, the global steerable robotic catheters market can be segmented into cardiac surgery, neurosurgery, vascular surgery, orthopedic surgery, uterine surgery, and others.

This market study includes drivers and restraints for the market along with the impact they have on the demand over the forecast period derived with the help of SWOT analysis.Global hyaluronic acid market is expected to rise to an estimated to register a substantial CAGR of 7.9% in the forecast period of 2019-2026Get Inside Scoop of the report, request for sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-hyaluronic-acid-marketMarket Definition: Global Hyaluronic Acid MarketHyaluronic acid is the fillers for reducing the wrinkles due to its antiaging property.

In addition, it provides solutions to orthopedic disorders.

Hyaluronic acid is a viscous substance that present in body naturally and act as a lubricants in joints, maintains the shape of eye ball and plays an important role in connecting tissues.

In chemical terms, hyaluronic acid is a long unbranched polysaccharide made up of repeated dimeric units of glucuronic acid and N-acetyl glucosamine.Top Manufacturers Covered in the Report:Few of the major market competitors currently working in the global hyaluronic acid market are F. Hoffmann-La Roche Ltd, SEIKAGAKU CORPORATION, Galderma Laboratories, L.P., Sanofi, Anika Therapeutics, Inc., Zimmer Biomet, ALLERGAN, Ferring B.V., Genzyme Corporation, TRB CHEMEDICA INTERNATIONAL SA, Merz Pharma, Meiji holdings Co., Ltd, ZEISS International, Fidia Farmaceutici s.p.a, LifeCore Biomedical LLC, Evonik Industries AG, Smith & Nephew, Bausch Health, Pfizer Inc., New Avon LLC and others.Focal points covered in this Hyaluronic Acid Market reportThis Hyaluronic Acid Market report provides pin point analysis of the market outlook and later establishes its comparison with current patterns.

Also it creates a relationship of the market outlook with Porter Five Force AnalysisThis research report is inclusive concept of the market progression.

The market progression considers the components of the present situation and compares the current scenario of the market with future developmental chances.The Hyaluronic Acid Market research report includes investigation at global and regional levels.

Global Bone Graft Substitute Market: Information by Type (Autograft, Demineralized Bone Matrix, Synthetic Bone Grafts, Bone Morphogenetic Protein and others), Application (Spinal Fusion, Joint Reconstruction, Long Bone, Dental, Foot & Ankle and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027 The Global Bone Graft Substitutes Market Share is predicted to touch USD 5031.0 million at a 6.52% CAGR over the forecast period (2014-2027), states the new Market Research Future (MRFR) report.

Often bone grafts are used for filling the empty space which has occurred between or in the bones of the spine due to deformity, injury, disease or surgical procedures, especially spinal fusion.

These factors, according to the latest MRFR report, include increasing prevalence of musculoskeletal disorders, technological advancements in the medical industry resulting to a shift to allograft from autograft, availability of biocompatible synthetic bone grafts, and rise in demand for dental bone grafts.

Additional factors pushing market growth include the development of innovative products, advancements in bone graft materials, the rapid increase in geriatric population, growing incidences of orthopedic disorders, improving healthcare infrastructure, demand for minimally invasive procedures, and increase in disposable income.

On the flip side, immune response and risk of disease transmission, stringent regulatory pathway, and ethical problems related to bone harvesting, are factors that may deter the bone graft substitutes market growth over the forecast period.

September 2019: A new bone graft substitute from Biogennix has recently received an FDA clearance.

Global Bioimplants Market: Information by Type (Cardiovascular Implant, Dental Implants), Material (Biological Materials, and Others), Origin (Autograft, Allograft, Synthetic, and Others), End-User (Hospitals, Clinics and Others) — Forecast till 2027Market Highlights:Bioimplants are essential in medical procedures which are conducted to recover the functionality of damaged bio structure.

Bioimplants are made up of biosynthetic materials such as ceramics, polymers and alloy and compatible for human body.

The increasing spinal cord injuries, technological advancements, rising occurrences of lifestyle disorders,  and growing geriatric population are the major factors driving the growth of the global bioimplants market.

Additionally, increasing R spending and aggressive strategies adopted by the top players, such as mergers and acquisitions, are contributing to the growth of the market.

For instance, in December 2017, Smith & Nephew acquired Rotation Medical Inc. for USD 125 million to expand its portfolio in bioimplants and to get access to the rotator cuff system of Rotation Medical.Thehigh costs associated with bioimplants, rising  cost of bioimplant surgeries, unfavorable reimbursement policies and dearth of technicians may hamper market growth during the assessment period.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6896Regional Analysis:The market in the Americas is expected to dominate the global bioimplants market during the forecast period owing to the growing geriatric population, increasing prevalence of chronic diseases, technological advancements in healthcare and rising occurrences of injuries related to spinal cord.

The European market is expected to be the second-largest due to government funding and support of the healthcare sector, increasing cardiovascular and orthopedic disorders in the region.

The global Fixed And Mobile C-arms Market size was valued at around USD 1.68 billion in 2016 and is expected to grow at a CAGR of 3.4% over the forecast period.

Mobile C-arms are exhibiting the fastest growth in this sector due to its mobility, flexibility and ease of use.

As the technology is advancing and newer accessories are being developed in the medical devices sector, mobile C-arms are continuously providing precise images with greater depth which would in turn help in getting faster and accurate diagnostic results.

Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/fixed-mobile-c-arms-market Government bodies of developing countries such as India, Mexico, and Brazil, are making huge investments to spread awareness regarding the application of C-arms, thereby focusing on patient-centric care.

These devices provide real-time detailed imaging of the anatomy and the real positing of the various organs, which proves to be helpful before various complicated surgeries.

Application Insights In the year 2016, orthopedics and trauma segment dominated the Fixed & Mobile C-arms Market market due to the device’s accurate image capturing capability with flexible positioning, efficiency, and versatility.

Expanding patient pool suffering from cancer, cardiovascular diseases, and dental and orthopedic disorders is primarily driving the need for dual and multi-energy computed tomography (CT) techniques.

Continuous focus on the introduction of technologically advanced devices is expected to propel the growth of the dual and multi-energy computed tomography market over the forecast period of 2019 to 2029.

These insights are based on a report on Dual and Multi-Energy Computed Tomography (CT) Market by Future Market Insights.Amidst the coronavirus pandemic, healthcare systems across the world are overwhelmed; they are running short of supplies such as viral testing kits.

This translates to increasing measures of isolation and medical screening.

Dual and multi-energy CT is crucial in the early detection of COVID-19, including its nature and extent of the damage.

As the number of confirmed cases of COVID-19 accelerates, especially in developed regions, dual and multi-energy CT would be critical in the large-scale screening of suspected individuals.For any Queries Linked with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/reports/sample/rep-gb-11301Key Takeaways of Dual and Multi-energy CT Market StudyThe dual-source CT segment under product type contributed maximum value share in the global dual and multi-energy CT market in 2018, owing to the increasing adoption of dual-source CT and easy availability of the device.CT angiography is expected to be the leading clinical application, resulting in a notable share of the segment in the dual and multi-energy computed tomography market.The hospital segment under end user holds above 50% of the value share in the dual and multi-energy CT market.North America holds around 35% revenue share and is expected to be the most lucrative region in the global dual and multi-energy computed tomography market during the forecast period.Increasing government funding to boost the growth of the medical industry in Asia is expected to drive the growth of the dual and multi-energy CT market in the region.Aging Population and Need for Medical ImagingIncreasing aging population with longer life expectancy, especially in developed regions, is anticipated to boost the medical and healthcare industry.According to the data of the National Institutes of Health (NIH), patients aging 65 years and above undergo diagnostic imaging at rate twice or thrice that of the younger population.

Global Platelet Rich Plasma (PRP) Market is estimated to reach USD 647.01 million by 2025 owing to the growing prevalence of orthopedic disorders like knee osteoarthritis, achilles tendinopathy, rotator cuff tears and increasing application of platelet rich plasma in cosmetic surgery.

Platelet rich plasma is a common treatment at present in the cosmetic (dermatological) field.It stimulates fibroblasts in the skin and makes them produce collagen fibers since (PRP) Platelet Rich Plasma is made from the patient’s body, the treatment is considered very safe.

It comprises proteins that act as cell adhesive molecules like fibrin, vitronectin, and fibronectin.Download Free Sample Report @ https://www.millioninsights.com/industry-reports/platelet-rich-plasma-prp-market/request-samplePlatelet rich plasma therapy has gained traction due to its wide application with no side-effects.

It is also used for treating injured tendons, joints, muscles, and ligaments.

It is also extensively used in cases of baldness that increases the blood flow and supports in hair growth.Since, the patient prefer minimally invasive surgeries, the cost of technological use is high.

The prevalence of orthopedic disorders that require surgery, continue to grow along with the trend of cosmetic surgeries in developed regions with a vast geriatric population.Platelet Rich Plasma industry is predicted to attain new heights across geographies.